ChartRow logo
Share this page
ABSI
$8.25-7.09%
as of close, Oct 16, 2026
☾ AH $8.25 -7.09%
Absci CorporationStock · HealthcareRussell 2000 0.05%US Stock Market 0.002%Russell 3000 0.002%
PeersMRNALLYMDTUNHJNJTMO

ABSI financial statements

The full income statement, balance sheet, and cash-flow statement for Absci Corporation (ABSI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 113.6M2024-09 114.9M2024-12 127.3M2025-03 127.6M2025-06 127.6M2025-09 143.8M2025-12 153.0M2026-03 155.9M2026-06 157.5M+38.7% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue2.80M-38.2%4.53M-20.7%5.72M-0.5%5.75M+20.2%4.78M+0.0%
123M+8.5%113M-6.4%121M+7.8%112M+40.6%80.0M+342.6%
Research & development81.4M+27.5%63.9M+32.9%48.1M-18.4%58.9M+32.1%44.6M+289.5%
Selling, general & administrative35.1M-3.1%36.2M-4.4%37.8M-6.7%40.6M+40.9%28.8M+423.1%
Amortization of intangibles3.40M+0.0%3.40M+0.0%3.40M+0.0%3.40M+61.9%2.10M
Operating income-120M-10.5%-109M+5.7%-116M-8.2%-107M-41.9%-75.2M-465.7%
Interest expense209K-63.0%565K-44.1%1.01M+3.9%972K-71.7%3.43M+441.3%
Other non-operating income5.41M-15.7%6.42M+5.9%6.06M+157.1%2.36M+107.6%-31.2M-7361.5%
Pre-tax income-115M-11.7%-103M+6.7%-110M-4.8%-105M+4.1%-110M-665.4%
Income tax69.0K-1.4%70.0K-30.0%100K+121.7%-461K+94.8%-8.90M
-115M-11.7%-103M+6.7%-111M-5.4%-105M-3.9%-101M-603.4%
Net income to common——-111M-5.4%-105M-1.6%-103M-108.7%
-$0.84+10.6%-$0.94+21.7%-$1.20-4.3%-$1.15+44.7%-$2.08+34.8%
EPS (basic)-$0.84+10.6%-$0.94+21.7%-$1.20-4.3%-$1.15+44.7%-$2.08+34.8%
Weighted-avg shares (basic)137M+24.1%110M+19.8%92.0M+1.3%90.8M+82.8%49.7M+220.7%
Weighted-avg shares (diluted)137M+24.1%110M+19.8%92.0M+1.3%90.8M+82.8%49.7M+220.7%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
150M+11.8%134M+11.0%121M-35.5%187M-31.6%273M+272.9%
Cash & equivalents20.0M-51.4%41.2M-43.0%72.4M+20.7%60.0M-76.3%253M+261.5%
Short-term investments124M+74.5%71.2M———
Accounts receivable—0.00-100.0%2.19M——
Prepaid expenses5.28M-3.3%5.46M+20.3%4.54M-22.6%5.86M-31.6%8.57M+383.5%
216M+1.3%214M-1.7%217M-32.3%321M-24.7%426M+381.2%
Operating lease right-of-use2.91M-26.6%3.97M-11.6%4.49M-15.6%5.32M-18.6%6.54M+46.1%
Goodwill——0.00-100.0%21.3M+0.0%21.3M
Intangible assets41.5M-7.5%44.9M-7.0%48.3M-6.5%51.6M-6.1%55.0M
Long-term investments
11.8M————
Other non-current assets383K-45.7%705K-54.1%1.54M+19.9%1.28M-0.9%1.29M+1086.2%
22.8M-20.6%28.7M-3.1%29.6M-2.4%30.3M-10.6%33.9M+235.4%
Accounts payable2.76M-6.5%2.95M+96.1%1.50M-37.7%2.41M-71.2%8.38M+296.3%
Accrued liabilities19.3M+182.8%6.84M+4.4%6.55M-68.0%20.5M+17.5%17.4M+1011.2%
Deferred revenue739K-33.8%1.12M-64.8%3.17M+613.3%445K-67.1%1.35M-48.6%
Current lease liability1.80M+12.3%1.61M-4.2%1.68M-0.7%1.69M+12.5%1.50M+95.1%
Finance lease liability (current)—78.0K-87.8%641K-72.1%2.30M-17.6%2.79M+88.8%
26.8M-22.1%34.5M-16.2%41.1M-11.7%46.6M-22.5%60.1M+178.6%
Long-term debt—3.99M-49.6%7.92M-27.6%10.9M+210.2%3.52M
Deferred revenue (non-current)436K0.00-100.0%966K0.00—
Non-current lease liability2.62M-40.8%4.43M-21.5%5.64M-22.9%7.32M-18.4%8.97M+135.2%
Operating lease liability (total)4.43M-26.6%6.04M-17.5%7.32M-18.7%9.01M-14.0%10.5M
Finance lease liability (total)—78.0K-89.1%717K-76.5%3.05M-49.4%6.02M
Finance lease liability——76.0K-89.9%750K-76.8%3.23M+16.8%
Deferred tax liabilities——186K-21.8%238K-68.0%743K
Other non-current liabilities1.02M+669.2%133K-54.9%295K+742.9%35.0K-99.7%12.2M+1523.8%
189M+5.8%179M+1.7%176M-35.8%274M-25.0%366M+509.4%
Preferred stock0.000.000.000.000.00
Common stock15.0K+25.0%12.0K+33.3%9.00K+0.0%9.00K+0.0%9.00K+350.0%
Additional paid-in capital814M+18.1%689M+18.2%583M+2.1%570M+2.4%557M-12.3%
Retained earnings-625M-22.6%-510M-25.4%-406M-37.4%-296M-54.9%-191M-112.1%
Accumulated other comprehensive income591K+14875.0%-4.00K+89.2%-37.0K+69.2%-120K-823.1%-13.0K
Total liabilities & equity216M+1.3%214M-1.7%217M-32.3%321M-24.7%426M+381.2%
Common shares issued—115M+23.9%93.1M+0.7%92.4M-0.3%92.6M+417.9%
Common shares outstanding—115M+23.9%93.1M+0.7%92.4M-0.3%92.6M+417.9%
Shares outstanding (cover)153M+20.2%127M+12.9%113M+22.2%92.3M-0.5%92.8M
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-92.9M-28.3%-72.4M-12.0%-64.6M+20.5%-81.3M-34.2%-60.6M-452.4%
Depreciation & amortization11.7M-12.3%13.4M-4.4%14.0M+7.4%13.0M+95.9%6.65M+488.3%
Intangible amortization3.40M+0.0%3.40M+0.0%3.40M+0.0%3.40M+61.9%2.10M
Share-based compensation18.3M-5.8%19.5M+70.4%11.4M-9.0%12.5M+18.2%10.6M+2425.7%
Deferred income taxes-98.0K-50.8%-65.0K-25.0%-52.0K+89.7%-505K+94.3%-8.90M
Change in receivables0.00+100.0%-2.24M-436.2%666K——
Change in payables1.09M-36.8%1.73M+320.2%-786K-47.5%-533K-133.9%1.57M+74.3%
Other operating activities-584K-129.6%1.97M+491.0%334K-53.7%721K+139.5%301K
-50.2M-20.6%-41.6M-150.7%81.9M+164.5%-127M-88.5%-67.4M-3003.5%
Capital expenditure1.11M+174.0%404K-53.0%860K-94.7%16.2M-57.5%38.0M+1644.5%
Free cash flow-94.0M-29.2%-72.8M-11.2%-65.5M+32.8%-97.5M+1.1%-98.6M-650.1%
Acquisitions0.000.000.00-100.0%8.00M-71.6%28.1M
Sales/maturities of investments69.5M-60.8%177M-26.7%242M——
Proceeds from sale of PP&E1.31M+39.7%939K+269.7%254K+91.0%133K0.00-100.0%
106M+28.4%82.5M+1940.9%-4.48M-185.6%5.24M-98.4%336M+373.7%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid3.12M-8.0%3.39M+12.5%3.01M-35.2%4.65M+190.7%1.60M+220.0%
Common stock issued106M+28.4%82.4M+9458.9%862K+31.4%656K-99.7%210M
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Net change in cash-37.1M-18.1%-31.5M-345.2%12.8M+106.3%-203M-197.5%208M+260.0%
Interest paid178K-68.3%561K-42.2%970K+8.4%895K+37.3%652K+28.3%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap534M+60.1%334M-14.5%390M+101.2%194M-74.5%761M
P/S190.7×+159.2%73.6×+30.8%56.3×+63.6%34.4×-78.4%159.1×
P/B2.8×+51.4%1.9×-6.3%2.0×+200.0%0.7×-68.1%2.1×
Source filing10-K10-K10-K10-K10-K

About this data

Source: ABSI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ABSI filings on SEC EDGAR → Not investment advice.